» Articles » PMID: 16185970

Endoscopic Resection of Benign Tumors of the Duodenal Papilla Without and with Intraductal Growth

Overview
Date 2005 Sep 28
PMID 16185970
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Endoscopic papillectomy of benign papillary tumor is still not widely practiced. Intraductal growth has been considered a contraindication for endoscopic therapy. This prospective study evaluates endoscopic papillectomy for treatment of benign papillary tumors without and with intraductal growth.

Methods: Monofilament snare and monopolar electrocoagulation were used for papillectomy. A 7F stent was placed in the pancreatic duct. Patients with distal intraductal growth underwent sphincterotomy and endoscopic resection after exclusion of more proximal growth.

Results: Between February 1985 and April 2004, 106 patients (109 lesions), 68 women, 38 men, median age 68 years (range 29-88 years) were included. Median tumor size was 2 cm (range 0.5-6 cm) with one session (range 1-8) required for removal. Nine patients had invasive carcinoma (8%). Surgery for incomplete removal or recurrence was performed in 12% of 75 patients without and 37% of 31 patients with intraductal growth (p < 0.01), respectively. Fifteen patients had recurrence (15%); but, only 4 required surgery. Endoscopic resection was curative (median follow-up, 43 months) in 83% without and 46% with intraductal growth (p < 0.001).

Conclusions: Endoscopic papillectomy is safe and effective, and may be feasible in cases of intraductal growth. Surveillance and, if required, re-treatment are mandatory because of the risk of recurrence.

Citing Articles

Safety of intrabiliary radiofrequency ablation in cases of residual and recurrent neoplasia after endoscopic papillectomy.

Dahel Y, Caillol F, Ratone J, Zemmour C, Palen A, Garnier J Endosc Int Open. 2025; 13:a24872598.

PMID: 39958668 PMC: 11827740. DOI: 10.1055/a-2487-2598.


Endoscopic Versus Surgical Treatment for Ampullary Lesions: A Systematic Review With Meta-Analysis.

Baroni L, Funari M, Kum A, Bestetti A, de Oliveira L, Ferreira de Carvalho M Cureus. 2024; 16(7):e65076.

PMID: 39170988 PMC: 11337076. DOI: 10.7759/cureus.65076.


Prophylactic pancreatic duct stenting to reduce the risk of post-ampullectomy pancreatitis: a comprehensive review and meta-analysis of 1858 patients.

Chandan S, Canakis A, Deliwala S, Frohlinger M, Khan S, Mohan B Surg Endosc. 2024; 38(9):4798-4813.

PMID: 39030415 DOI: 10.1007/s00464-024-11019-y.


New Method of Papillectomy May Decrease Recurrence: Anchoring Method versus Conventional Method.

Lee J, Park Y, Han S, Joo D, Hong S, Yi K J Clin Med. 2024; 13(11).

PMID: 38892937 PMC: 11172506. DOI: 10.3390/jcm13113226.


Long-term Outcomes of Ampullary Adenoma According to Resected Margin Status after Endoscopic Papillectomy.

Lee J, Oh D, Seo D, Song T, Park D, Lee S Gut Liver. 2024; 18(4):747-755.

PMID: 38715439 PMC: 11249933. DOI: 10.5009/gnl230451.